Zenith Drugs Limited

19 Feb 2024 - 22 Feb 2024 Individual Category SME IPO NSE

Min Investment

₹240000

Price Band

₹75-₹79

Issue Size

38.61 lakhs
Equity Shares

Lot Size

1600 (per lot)

IPO Dates
img

19 Feb 2024

Open Date

img

22 Feb 2024

Close Date

img

23 Feb 2024

Allotment Date

img

27 Jul 2024

Listing Date

Zenith Drugs Limited IPO 2024 is open for subscription from Monday, February 19, 2024 and will close on Thursday, February 22, 2024. The price band is decided at Rs 75 to Rs 79 per share. The minimum lot size of this application for the retail category is 1600 shares. Whereas, the minimum lot size for HNI category is 2 lots consisting of 3200 shares. The minimum amount of investment required for retail category investors is Rs 1,26,400 (79 x 1600 shares). However for HNI category the minimum investment amount is required Rs 2,52,800 (79 x 3200 shares). Zenith Drugs Limited IPO 2024 is a book-built issue of Rs 40.68 crores. The issue is entirely a fresh issue of 51.49 lakh equity shares. The allotment for this IPO is expected to be finalized on Friday, February 23, 2024. Zenith Drugs Limited IPO will list on NSE SME and listing date fixed on Monday, February 27, 2024. The book running lead manager of Zenith Drugs Limited IPO is Gretex Corporate Services Limited. The registrar for this IPO is Bigshare Services Private Limited. The market maker for the Zenith Drugs Limited IPO is Gretex Share Broking.

Know Before Investing

Strengths icon

Weaknesses icon

About Zenith Drugs Limited

Zenith Drugs is a pharmaceutical company incorporated in 2000, it specializes in manufacturing and trading high quality affordable medicines including generic drugs. Company is based in Indore, since its inception, the company has focused on building a strong foundation and laying the groundwork for its future growth and success. Company was incorporated with an objective of delivering better service in the field of medicine and being a better premium pharmaceutical company in India and abroad. Company’s always emphasis on core strength and policies that focus on technology and great deliverance. The portfolio of the company include, ORS powder, Liquid Orals, Ointments, Liquid Externals and Capsules. The Food and Drugs association has approved 600 products, from which 325 are in production. Company is in the process of setting up a new manufacturing facility in Village, Muradpura, Depalpur, Indore Madhya pradesh. Company supplies its products to countries such as Costa Rica in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.

Founded

2000

Managing Director

Sandeep Bharadwaj

Parent Organization

IPO Objectives

The funds raised from the issue will be utilized to purchase the Machinery and equipment for a new manufacturing unit. Moreover, the funds will also be used to upgrade the existing manufacturing blocks. Other than this, proceeds from the issue will cover the working capital requirements and general corporate purposes.

Company Promoters

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0
img

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account